OPKO Health Total Assets 2012-2026 | OPK

OPKO Health total assets from 2012 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
OPKO Health Annual Total Assets
(Millions of US $)
2025 $1,932
2024 $2,200
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
OPKO Health Quarterly Total Assets
(Millions of US $)
2026-06-30 $1,829
2026-03-31 $1,857
2025-12-31 $1,932
2025-09-30 $1,996
2025-06-30 $1,973
2025-03-31 $2,128
2024-12-31 $2,200
2024-09-30 $2,256
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.164B $0.607B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.884B 25.75
Intuitive Surgical (ISRG) United States $133.518B 45.26
Edwards Lifesciences (EW) United States $49.242B 30.43
IQVIA Holdings (IQV) United States $43.729B 23.39
Waters (WAT) United States $40.283B 29.97
IDEXX Laboratories (IDXX) United States $40.144B 35.83
Alcon (ALC) Switzerland $33.505B 20.78
DexCom (DXCM) United States $31.955B 33.21
Mettler-Toledo (MTD) United States $25.762B 28.65
STERIS (STE) Ireland $20.832B 20.50
SONOVA HOLDING (SONVY) Switzerland $16.759B 0.00
Hologic (HOLX) United States $16.752B 17.53
Coloplast (CLPBY) Denmark $14.762B 17.70
Penumbra (PEN) United States $12.599B 83.08
Fresenius Medical Care AG KGaA (FMS) Germany $12.279B 8.59
Globus Medical (GMED) United States $10.173B 15.40
Glaukos (GKOS) United States $10.092B 0.00
Masimo (MASI) United States $9.578B 30.69
SARTORIUS (SSSGY) Germany $7.521B 43.67
Sysmex ADR (SSMXY) Japan $7.390B 27.95
Teleflex (TFX) United States $5.521B 14.89
LivaNova (LIVN) United Kingdom $4.442B 22.46
Integer Holdings (ITGR) United States $4.287B 19.86
Pulse Biosciences (PLSE) United States $3.752B 0.00
Veracyte (VCYT) United States $3.313B 27.11
TransMedics (TMDX) United States $2.967B 43.58
AxoGen (AXGN) United States $2.354B 0.00
UFP Technologies (UFPT) United States $2.153B 27.17
Elekta AB (EKTAY) Sweden $1.883B 17.62
Nihon Kohden (NHNKY) Japan $1.694B 15.52
Alphatec Holdings (ATEC) United States $1.677B 0.00
Alpha Tau Medical (DRTS) Israel $1.301B 0.00
Integra LifeSciences Holdings (IART) United States $1.222B 6.36
Artivion (AORT) United States $1.217B 46.24
PROCEPT BioRobotics (PRCT) United States $1.204B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.171B 27.77
Tandem Diabetes Care (TNDM) United States $1.170B 0.00
IRadimed (IRMD) United States $1.055B 46.11
Anteris Technologies Global (AVR) Australia $0.850B 0.00
SiBone (SIBN) United States $0.829B 0.00
Beta Bionics (BBNX) United States $0.753B 0.00
Mesa Laboratories (MLAB) United States $0.680B 16.37
AngioDynamics (ANGO) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.583B 0.00
Delcath Systems (DCTH) United States $0.570B 1644.00
Tactile Systems Technology (TCMD) United States $0.511B 20.90
NeuroPace (NPCE) United States $0.501B 0.00
Sight Sciences (SGHT) United States $0.448B 0.00
Pacific Biosciences Of California (PACB) United States $0.420B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
908 Devices (MASS) United States $0.402B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.371B 0.00
Mobia Medical (MOBI) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Treace Medical Concepts (TMCI) United States $0.301B 0.00
Spectral Diagnostics (EDTXF) Canada $0.266B 0.00
RxSight (RXST) United States $0.254B 0.00
Neuronetics (STIM) United States $0.221B 0.00
Lucid Diagnostics (LUCD) United States $0.159B 0.00
FocalTherics (FOCL) France $0.154B 0.00
Inogen (INGN) United States $0.139B 0.00
EDAP TMS S.A (EDAP) France $0.124B 0.00
Microbot Medical (MBOT) United States $0.097B 0.00
LENSAR (LNSR) United States $0.096B 0.00
Hyperfine (HYPR) United States $0.085B 0.00
Zomedica (ZOMDF) United States $0.083B 0.00
CVRx (CVRX) United States $0.080B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.071B 23.27
DarioHealth (DRIO) United States $0.069B 0.00
Positron (POSC) United States $0.059B 0.00
Rapid Micro Biosystems (RPID) United States $0.059B 0.00
Envoy Medical (COCH) United States $0.056B 0.00
Nano-X Imaging (NNOX) Israel $0.055B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Sensus Healthcare (SRTS) United States $0.052B 0.00
Precision Optics (POCI) United States $0.048B 0.00
Baird Medical Investment Holdings (BDMD) $0.045B 0.00
InspireMD (NSPR) United States $0.038B 0.00
QT Imaging Holdings (QTI) United States $0.036B 0.00
PAVmed (PAVM) United States $0.035B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Accuray (ARAY) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.004B 0.00
Tenon Medical (TNON) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
NexGel (NXGL) United States $0.003B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.000B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00